1025 related articles for article (PubMed ID: 16901971)
21. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
22. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
23. ERα/ERβ-directed CBS transcription mediates E2β-stimulated hUAEC H2S production.
Bai J; Lechuga TJ; Makhoul J; Yan H; Major C; Hameed A; Chen DB
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36476832
[TBL] [Abstract][Full Text] [Related]
24. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.
Maruyama S; Fujimoto N; Asano K; Ito A
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):177-84. PubMed ID: 11566442
[TBL] [Abstract][Full Text] [Related]
25. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
26. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
[TBL] [Abstract][Full Text] [Related]
27. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
29. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
[TBL] [Abstract][Full Text] [Related]
30. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
31. A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERα and/or ERβ transactivation.
Martinho A; Santos CR; Gonçalves I
Gene; 2013 Sep; 527(2):469-76. PubMed ID: 23860318
[TBL] [Abstract][Full Text] [Related]
32. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
33. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
34. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
35. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845
[TBL] [Abstract][Full Text] [Related]
38. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C
Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]